RALEIGH, N.C., June 25, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that as of June 11, 2009 it has gained the allowance and grant of an additional 10 patents to its portfolio (9 granted and 1 allowed) over the past 18 months. The territories involved are the United States, Europe, the Russian Federation, India, Australia, Indonesia and Japan. The European patent was registered in 26 European countries. The expiration dates range from 2018 to 2023 with the majority expiring in 2022. The new patents are related to our lead drug candidates in the fields of diabetes and pain.
